ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 25 filers reported holding ARGOS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $406,000 | -55.9% | 82,850 | -55.2% | 0.27% | -14.6% |
| Q3 2016 | $920,000 | -18.9% | 185,097 | 0.0% | 0.31% | -30.8% |
| Q2 2016 | $1,135,000 | -8.8% | 185,097 | -4.8% | 0.45% | -12.0% |
| Q1 2016 | $1,244,000 | +108.7% | 194,400 | -24.6% | 0.52% | +207.1% |
| Q4 2015 | $596,000 | -52.1% | 257,900 | 0.0% | 0.17% | -29.4% |
| Q3 2015 | $1,243,000 | -60.2% | 257,900 | -43.5% | 0.24% | -19.3% |
| Q2 2015 | $3,127,000 | -24.5% | 456,500 | -1.8% | 0.30% | -24.6% |
| Q1 2015 | $4,142,000 | -12.8% | 464,900 | -2.1% | 0.39% | -14.3% |
| Q4 2014 | $4,751,000 | -0.6% | 475,100 | 0.0% | 0.46% | -7.5% |
| Q3 2014 | $4,780,000 | +13.9% | 475,100 | -9.1% | 0.49% | +36.9% |
| Q2 2014 | $4,196,000 | -19.0% | 522,500 | +0.9% | 0.36% | -14.9% |
| Q1 2014 | $5,178,000 | – | 517,800 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARXE AUSTIN W & GREENHOUSE DAVID M | 750,000 | $7,545,000 | 1.03% |
| WALL STREET ASSOCIATES | 475,100 | $4,780,000 | 0.49% |
| WASATCH ADVISORS LP | 1,158,344 | $11,653,000 | 0.12% |
| Pinnacle Summer Investments, Inc. | 92,415 | $929,000 | 0.10% |
| ALTRINSIC GLOBAL ADVISORS LLC | 250,000 | $2,515,000 | 0.05% |
| STONERIDGE INVESTMENT PARTNERS LLC | 25,811 | $260,000 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 22,704 | $228,000 | 0.03% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 701,900 | $7,061,000 | 0.02% |
| Alyeska Investment Group, L.P. | 79,430 | $799,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 500 | $5,000 | 0.01% |